Evidence map›Paper›PMID 30227746›Full record

ArticleBioTechniques2018

Proximity ligation assay to study protein-protein interactions of proteins on two different cells.

Rushikesh Sable, Nithya Jambunathan, Sitanshu Singh, Sandeep Pallerla, Konstantin G Kousoulas, Seetharama Jois

Open access · goldAbstract read
In one paragraph

Article in BioTechniques, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Design of aptamer peptides for immunomodulation.Journal of enzyme inhibition and medicinal chemistry · 2026
    Article
  2. Article
  3. Journal of proteome research · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rushikesh SableBasic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, LA 71201, USA.
Nithya JambunathanDivision of Biotechnology & Molecular Medicine & Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
Sitanshu SinghBasic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, LA 71201, USA.
Sandeep PallerlaBasic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, LA 71201, USA.
Konstantin G KousoulasDivision of Biotechnology & Molecular Medicine & Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
Seetharama JoisBasic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, LA 71201, USA.
University of Louisiana at Monroe · USLouisiana State University · US

Funding

STABILITY' (symptomatic review during biologic therapy) Review in Inflammatory Bowel DiseaseP20GM103424 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI Seetharama D Jois · 2012 to 2026
$57.4M
Molecular mechanism of EGFR heterodimerization: inhibition by a peptidomimeticR15CA188225 · NCI · UNIVERSITY OF LOUISIANA AT MONROE · PI JOIS, SEETHARAMA D · 2015 to 2015
$394k
NCI NIH HHS R15 CA188225NIGMS NIH HHS P20 GM103424
6 · The paper itself

Abstract

Protein-protein interactions (PPI) by homo-, hetero- or oligo-merization in the cellular environment regulate cellular processes. PPI can be inhibited by antibodies, small molecules or peptides, and this inhibition has therapeutic value. A recently developed method, the proximity ligation assay (PLA), provides detection of PPI in the cellular environment. However, most applications using this assay are for proteins expressed in the same cell. We employ PLA for the first time to study PPI of cell surface proteins on two different cells. Inhibition of PPI using a peptide inhibitor is also quantified using this assay; PLA is used to detect PPI of CD2 and CD58 between Jurkat cells (T cells) and human fibroblast-like synoviocyte-rheumatoid arthritis cells that are important in the immune response in the autoimmune disease rheumatoid arthritis. This assay provides direct evidence of inhibition of PPI of two proteins on different cell surfaces.

Indexed as

BiotechnologyCD2 AntigensCD58 AntigensCells, CulturedFlow CytometryHistocompatibility Antigens Class IIHumansJurkat CellsMembrane ProteinsModels, MolecularProtein BindingProteinsSynoviocytesCD2 AntigensCD58 AntigensHistocompatibility Antigens Class IIMembrane ProteinsProteinsassaysbioanalysisflourescence

Identifiers

PMID30227746
PMCPMC6770473
OpenAlexW2890273323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.